Search Results 111-120 of 17906 for Crohns disease

1. Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease - Mayo Clinic

   About this study. The purpose of study is to test the effects of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...

2. Adverse effects related to Heplisav-B vaccination in patients with Inflammatory Bowel Disease - Mayo Clinic

   ... Crohn's disease. It is now the standard of practice vaccine that we use in ... IBD and chronic liver disease. In this study, we aim to collect data on ...

3. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease - Mayo Clinic

   ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

4. Diarrhea Causes - Mayo Clinic

   Crohn's disease a kind of disease that causes the bowels to swell. Inflammatory bowel disease (IBD) · Irritable bowel syndrome; Medications used to treat ...

5. Budesonide (oral route) - Mayo Clinic

   ... Crohn's disease, an inflammatory bowel disease. This medicine works inside the intestines (bowels) to reduce inflammation and symptoms of the disease. It ...

6. A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease - Mayo Clinic

   Clinical Trials · A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease · More about research at Mayo Clinic · Mayo Clinic Footer.

7. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

   ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

8. Examining the use of endoscopic bariatric therapy in patients with IBD - Mayo Clinic

   Five individuals with inflammatory bowel disease (IBD) and obesity experienced effective weight loss after endoscopic bariatric therapy (EBT).

9. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

   Prospective disease evaluation, improved control of confounding factors, and obesity measures that reflect visceral adipose tissue are needed to understand ...

10. Vaccine efficacy and antibody response among patients with IBD and recipients of immunosuppressive agents - Mayo Clinic

    Clinicians who care for patients with inflammatory bowel disease (IBD) or other autoimmune diseases are concerned about the efficacy of coronavirus disease ...